Gemina Laboratories Ltd.

CNSX:GLAB Stock Report

Market Cap: CA$47.0m

Gemina Laboratories Management

Management criteria checks 1/4

Gemina Laboratories' CEO is Brian Firth, appointed in Sep 2022, has a tenure of 2.33 years. directly owns 0.067% of the company’s shares, worth CA$31.50K. The average tenure of the management team and the board of directors is 2.9 years and 3 years respectively.

Key information

Brian Firth

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownership0.07%
Management average tenure2.9yrs
Board average tenure3yrs

Recent management updates

Recent updates

Will Gemina Laboratories (CSE:GLAB) Spend Its Cash Wisely?

Oct 17
Will Gemina Laboratories (CSE:GLAB) Spend Its Cash Wisely?

Is Gemina Laboratories (CSE:GLAB) In A Good Position To Invest In Growth?

Mar 10
Is Gemina Laboratories (CSE:GLAB) In A Good Position To Invest In Growth?

CEO Compensation Analysis

How has Brian Firth's remuneration changed compared to Gemina Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-CA$4m

Apr 30 2024n/an/a

-CA$4m

Jan 31 2024n/an/a

-CA$5m

Oct 31 2023n/an/a

-CA$6m

Jul 31 2023n/an/a

-CA$6m

Apr 30 2023n/an/a

-CA$7m

Jan 31 2023CA$104kCA$104k

-CA$6m

Compensation vs Market: Insufficient data to establish whether Brian's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare Brian's compensation with company performance.

CEO

Brian Firth

2.3yrs

Tenure

CA$104,167

Compensation

Mr. Brian Firth is Chief Executive Officer of Gemina Laboratories Ltd. from September 1,2022 and also serves as its Director since January 12, 2023. He brings to Gemina an enviable career, focused on healt...

Leadership Team

NamePositionTenureCompensationOwnership
Brian Firth
CEO & Director2.3yrsCA$104.17k0.067%
CA$ 31.5k
Michael Liggett
CFO & Company Secretary3.8yrsCA$57.14kno data
Robert Greene
CTO & Director4.3yrsCA$155.66k0.056%
CA$ 26.5k
Hugh McNaught
VP of Marketing & Member of Advisory Boardno datano datano data
David Browning
Head of Productization & Director of Gemina Laboratories (UK) Limited2.9yrsno datano data
Christine Buerki
Head of Product Development2yrsno datano data

2.9yrs

Average Tenure

Experienced Management: GLAB's management team is considered experienced (2.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Brian Firth
CEO & Director2yrsCA$104.17k0.067%
CA$ 31.5k
Robert Greene
CTO & Director4yrsCA$155.66k0.056%
CA$ 26.5k
Hugh McNaught
VP of Marketing & Member of Advisory Board5yrsno datano data
Michael Shannon
Chair of Clinical Advisory Board2.1yrsno datano data
John Davies
Independent Chairman4yrsCA$107.25k0.054%
CA$ 25.2k
Martin Cronin
Independent Director3.8yrsCA$10.00k0.098%
CA$ 46.0k
Bola Grace
Independent Director2yrsCA$324.00no data
Martha Najib
Independent Director1.8yrsno datano data

3.0yrs

Average Tenure

Experienced Board: GLAB's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/17 06:35
End of Day Share Price 2025/01/14 00:00
Earnings2024/07/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gemina Laboratories Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution